Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LGND, LGNDZ | LIGAND PHARMACEUTICALS INC | Director | $468K | Jun 14, 2024 | ||
SYRS | Syros Pharmaceuticals, Inc. | Chief Financial Officer | $0 | +$161K | Nov 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|